首页> Frontiers in oncology> Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck.

Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck.

导出 LinkOut

翻译打印收藏纠错

第一作者： Emmanuel,Seront

第一单位： Department of Medical Oncology, Centre Hospitalier de Jolimont, La Louvière, Belgium.;Departments of Medical Oncology and Head and Neck Surgery, Institut Roi Albert II, Institut de Recherche Clinique et Expérimentale (Pole MIRO), Cliniques Universitaires Saint-Luc, Catholic University of Louvain, Woluwe-Saint-Lambert, Belgium.

作者： Emmanuel,Seront ^[1] ; Sandra,Schmitz ^[2] ; Matthias,Papier ^[2] ; Aline,van Maanen ^[3] ; Stéphanie,Henry ^[4] ; Christophe,Lonchay ^[5] ; Sylvie,Rottey ^[6] ; Gabrielle,van Caloen ^[7] ; Jean-Pascal,Machiels ^[2]

作者单位： Department of Medical Oncology, Centre Hospitalier de Jolimont, La Louvière, Belgium.;Departments of Medical Oncology and Head and Neck Surgery, Institut Roi Albert II, Institut de Recherche Clinique et Expérimentale (Pole MIRO), Cliniques Universitaires Saint-Luc, Catholic University of Louvain, Woluwe-Saint-Lambert, Belgium. ^[1] Departments of Medical Oncology and Head and Neck Surgery, Institut Roi Albert II, Institut de Recherche Clinique et Expérimentale (Pole MIRO), Cliniques Universitaires Saint-Luc, Catholic University of Louvain, Woluwe-Saint-Lambert, Belgium. ^[2] Statistical Support Unit, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Belgium. ^[3] Department of Medical Oncology, Centre de Maternité Sainte Elisabeth, Namur, Belgium. ^[4] Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium. ^[5] Department of Medical Oncology, University Hospital Ghent, Ghent, Belgium. ^[6] Laboratory of Medical Oncology, Institut Roi Albert II, Institut de Recherche Clinique et Expérimentale (Pole MIRO), Catholic University of Louvain, Namur, Belgium. ^[7]

关键词 HPV cetuximab head and neck recurrent ribociclib squamous cell carcinoma

DOI 10.3389/fonc.2019.00155

PMID 30941307

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交